Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSK OTC Boycott Urged In Multi-State “Tums Down” Campaign

This article was originally published in The Tan Sheet

Executive Summary

Senior advocacy groups in more than 10 states across the country are urging consumers to boycott GlaxoSmithKline's OTC drug products through press events and postcards, e-mails and telephone calls to GSK and congressional leaders

You may also be interested in...



Pfizer OTCs Subject Of Boycott By Seniors Group Over Reimportation Stance

A 25,000-member senior citizen organization is heading a boycott of Pfizer's over-the-counter drug products in protest of the firm's stance on reimportation of prescription drugs from Canada

Pfizer OTCs Subject Of Boycott By Seniors Group Over Reimportation Stance

A 25,000-member senior citizen organization is heading a boycott of Pfizer's over-the-counter drug products in protest of the firm's stance on reimportation of prescription drugs from Canada

Pfizer OTCs Subject Of Boycott By Seniors Group Over Reimportation Stance

A 25,000-member senior citizen organization is heading a boycott of Pfizer's over-the-counter drug products in protest of the firm's stance on reimportation of prescription drugs from Canada

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel